Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

NCT01836692 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

RADIATION: Intensity Modulated Radiotherapy treatment

Sponsor

Prof Corinne Faivre-Finn

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]